Skip to content

Serum or Plasma Quantitative Immunoassay for Anti-Cardiolipin Antibodies (IgG and IgM)

Published: August 9, 2026Updated: August 16, 2026

This test measures the levels of antibodies (IgG and IgM) that target cardiolipin, a protein found in cell membranes. These antibodies may indicate an autoimmune response.

Quick summary

["Assesses immune system involvement in potential autoimmune conditions linked to cardiolipin antibodies."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
9963-0
Short code
QRS I-Amp L-AVR
Synonyms
QRS I-Amp L-AVR
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
ekg
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The test detects two types of antibodies: IgG and IgM, which target cardiolipin—a protein associated with cell membranes. These antibodies can be part of a broader autoimmune response, often linked to conditions like lupus or other connective tissue disorders.

Why Might You Need This Test?

Your healthcare provider may order this test if you have symptoms suggestive of autoimmune diseases, such as joint pain, fatigue, or unexplained blood clots. It can also be used to monitor certain conditions like antiphospholipid syndrome.

What Does a Positive Result Mean?

A positive result suggests the presence of elevated cardiolipin antibodies, which may indicate an autoimmune response. However, this alone doesn’t diagnose a specific condition—results are usually interpreted alongside clinical symptoms and other tests.

How Is This Test Performed?

A blood sample is drawn, and the serum or plasma is tested using an immunoassay method to measure antibody levels. The test is typically done in a lab and may take several days for results.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Anti-cardiolipin antibodies are often associated with autoimmune diseases like systemic lupus erythematosus (SLE) or antiphospholipid syndrome (APS), which can increase the risk of blood clots, miscarriages, or chronic inflammation. While not definitive, elevated levels may prompt further evaluation for these conditions.

Short name

Anti-Cardiolipin Antibody Test

Frequently asked questions

What Are Common Symptoms That Might Lead to This Test?
Symptoms that may prompt this test include persistent joint pain, fatigue, unexplained blood clots, recurrent miscarriages, or skin rashes. Always discuss symptoms with your healthcare provider.
How Often Should This Test Be Done?
The frequency depends on your condition and treatment. If you have an autoimmune disorder, your provider may recommend periodic testing to monitor antibody levels and adjust treatment as needed.
Can Diet or Supplements Affect This Test?
Dietary changes or supplements (like high-dose vitamin E or omega-3s) may influence antibody levels, so it’s important to inform your provider of any supplements you’re taking before testing.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy